← Open Payments lookup

DZUNG NGUYEN: Open Payments

NPI 1285108944 · WESTMINSTER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$522 in 20 payments from 9 companies in 2025. Trend: 2023 $96 · 2024 $401 · 2025 $522

Food & beverage: $522
CompanyPaymentsAmount
UCB, Inc.7$180
Madrigal Pharmaceuticals4$154
Amgen Inc.2$39
Merck Sharp & Dohme LLC2$34
Novartis Pharmaceuticals Corporation1$33
Dexcom, Inc.1$24
Novo Nordisk Inc1$20
Phadia US Inc.1$19
Lilly USA, LLC1$18

Products named: REZDIFFRA, Briviact, Nayzilam, OTEZLA, GARDASIL 9, LEQVIO, Dexcom G6 Transmitter, ImmunoCAP.

Industry payments across CA — which companies pay providers there.